The CETI (Cell Enhancement and Technologies for Immunotherapy) Program is led by Dr. Catherine Bollard, a Tenured Professor of Pediatrics & Microbiology, Immunology, and Tropical Medicine at GW. Dr. Eric Yvon , an Associate Professor at GW, directs our GMP facility, which will generate clinical grade cell therapy products for trials. Dr. Conrad Russell Cruz, an Assistant Professor at GW, leads our pre-clinical studies in the GW Cancer Center.
The CETI Program is housed within the Department of Pediatrics in the Cancer Center at The George Washington University, School of Medicine and Health Sciences. Our lab focuses on developing potent gene-modified cell-based immunotherapies for targeting cancer and HIV. Our sister CETI lab is located at the Children’s National Health System in Washington D.C.